Suven Pharmaceuticals Ltd - Updates on Open Offer

Kotak Mahindra Capital Company Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Post-Offer Advertisement in accordance with Regulation 18(7) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, and Corrigendum to the Detailed Public Statement for the attention of the public shareholders of Suven Pharmaceuticals Ltd ("Target Company").